Sure, having a cold or respiratory infection can temporarily make it harder to breathe. But if excessive coughing and ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

There are several tests that doctors can use to diagnose and monitor COPD. Let's take a look at what abnormal values for ...

Since the opening of that first clinic in rural Maryland, they’ve opened 10 others, including the first-ever pulmonary rehab ...

Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into ...

The decision could significantly expand use of what is already one of the industry’s best-selling ... pulmonary disease, or COPD, that can’t be controlled with other medications.

The company has said it expects the target COPD patient population eligible ... Analysts on average expect Dupixent, by far Sanofi's best-selling drug, to generate more than 21 billion euros ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

For the 16 million Americans with chronic obstructive pulmonary disease (COPD), travel can be as anxiety ... In this plan, you'll take actions and use the medications and therapies specific ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation.

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...